Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Gross Margin: 2016-2024

Historic Gross Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to 75.99%.

  • Organogenesis Holdings' Gross Margin fell 1200.00% to 64.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 66.27%, marking a year-over-year decrease of 902.00%. This contributed to the annual value of 75.99% for FY2024, which is 57.00% up from last year.
  • Organogenesis Holdings' Gross Margin amounted to 75.99% in FY2024, which was up 0.76% from 75.42% recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Gross Margin peaked at 76.71% during FY2022, and registered a low of 74.19% during FY2020.
  • Moreover, its 3-year median value for Gross Margin was 75.99% (2024), whereas its average is 76.04%.
  • In the last 5 years, Organogenesis Holdings' Gross Margin soared by 329bps in 2020 and then plummeted by 129bps in 2023.
  • Organogenesis Holdings' Gross Margin (Yearly) stood at 74.19% in 2020, then spiked by 138bps to 75.57% in 2021, then surged by 114bps to 76.71% in 2022, then plummeted by 129bps to 75.42% in 2023, then soared by 57bps to 75.99% in 2024.